Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jop Mostert

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|May 12, 2023
Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosisEva M Strijbis, Eline Coerver, Jop Mostert, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 28, 2026
Breaking the PROMISE: poor association between brain volume loss and clinical disability worsening over 2 years of follow-up in primary progressive multiple sclerosisMarcus Koch, Jop Mostert, Eva M Strijbis, et al.
Neurology|February 17, 2025
Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple SclerosisEva M M Strijbis, Jop Mostert, Jacynthe Comtois, et al.
European Journal of Neurology|May 12, 2023
Association between age and inflammatory disease activity on magnetic resonance imaging in relapse onset multiple sclerosis during long-term follow-upEline Coerver, Sophie Janssens, Aroosa Ahmed, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 13, 2023
Relapse recovery in relapsing-remitting multiple sclerosis: An analysis of the CombiRx datasetMarcus W Koch, Ester Moral, Luis Brieva, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|November 22, 2017
Extremely Painful Multifocal Acquired Predominant Axonal Sensorimotor Neuropathy of the Upper LimbDoris Lieba-Samal, Jeroen J J van Eijk, Marieke H J van Rosmalen, et al.
Neurology|December 6, 2024
Feasibility of Simon 2-Stage Futility Trials in Early Parkinson Disease: Analysis of the PRECEPT and DATATOP Trial DatasetsMarcus Werner Koch, Lorraine V Kalia, Justyna R Sarna, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 8, 2025
Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS studyVictoria M Leavitt, Robert Fox, Jop Mostert, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 21, 2025
Feasibility of Simon Two-Stage Futility Trials in People with Early, Symptomatically Treated Parkinson's DiseaseMarcus W Koch, Lorraine V Kalia, Justyna Sarna, et al.
Neurology|June 18, 2026
Phase 2 Futility Trials in Alzheimer Disease and Mild Cognitive Impairment: A Cohort Analysis of the ADNI Data SetAravind Ganesh, Eric E Smith, Jop Mostert, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Journal of Neurology, Neurosurgery, and Psychiatry|May 12, 2023
Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosisEva M Strijbis, Eline Coerver, Jop Mostert, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 28, 2026
Breaking the PROMISE: poor association between brain volume loss and clinical disability worsening over 2 years of follow-up in primary progressive multiple sclerosisMarcus Koch, Jop Mostert, Eva M Strijbis, et al.
Neurology|February 17, 2025
Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple SclerosisEva M M Strijbis, Jop Mostert, Jacynthe Comtois, et al.
European Journal of Neurology|May 12, 2023
Association between age and inflammatory disease activity on magnetic resonance imaging in relapse onset multiple sclerosis during long-term follow-upEline Coerver, Sophie Janssens, Aroosa Ahmed, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 13, 2023
Relapse recovery in relapsing-remitting multiple sclerosis: An analysis of the CombiRx datasetMarcus W Koch, Ester Moral, Luis Brieva, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|November 22, 2017
Extremely Painful Multifocal Acquired Predominant Axonal Sensorimotor Neuropathy of the Upper LimbDoris Lieba-Samal, Jeroen J J van Eijk, Marieke H J van Rosmalen, et al.
Neurology|December 6, 2024
Feasibility of Simon 2-Stage Futility Trials in Early Parkinson Disease: Analysis of the PRECEPT and DATATOP Trial DatasetsMarcus Werner Koch, Lorraine V Kalia, Justyna R Sarna, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 8, 2025
Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS studyVictoria M Leavitt, Robert Fox, Jop Mostert, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 21, 2025
Feasibility of Simon Two-Stage Futility Trials in People with Early, Symptomatically Treated Parkinson's DiseaseMarcus W Koch, Lorraine V Kalia, Justyna Sarna, et al.
Neurology|June 18, 2026
Phase 2 Futility Trials in Alzheimer Disease and Mild Cognitive Impairment: A Cohort Analysis of the ADNI Data SetAravind Ganesh, Eric E Smith, Jop Mostert, et al.
Pageof 5